AU1121997A - Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product - Google Patents

Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product

Info

Publication number
AU1121997A
AU1121997A AU11219/97A AU1121997A AU1121997A AU 1121997 A AU1121997 A AU 1121997A AU 11219/97 A AU11219/97 A AU 11219/97A AU 1121997 A AU1121997 A AU 1121997A AU 1121997 A AU1121997 A AU 1121997A
Authority
AU
Australia
Prior art keywords
gdnf
cell line
protein product
neurotrophic factor
derived neurotrophic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11219/97A
Inventor
Christine Matheson
Qial Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU1121997A publication Critical patent/AU1121997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/185Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU11219/97A 1995-11-29 1996-11-22 Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product Abandoned AU1121997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56484495A 1995-11-29 1995-11-29
US564844 1995-11-29
PCT/US1996/018729 WO1997019693A1 (en) 1995-11-29 1996-11-22 Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product

Publications (1)

Publication Number Publication Date
AU1121997A true AU1121997A (en) 1997-06-19

Family

ID=24256129

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11219/97A Abandoned AU1121997A (en) 1995-11-29 1996-11-22 Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product

Country Status (2)

Country Link
AU (1) AU1121997A (en)
WO (1) WO1997019693A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677135B1 (en) 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product
SI1005358T1 (en) * 1997-07-30 2003-06-30 Amgen Inc. Use of a neurturin protein product for preventing and treating hearing loss
US7067473B1 (en) 1998-07-14 2006-06-27 Janssen Pharmaceutica N.V. Neurotrophic growth factor
DE60021360T2 (en) * 1999-04-15 2006-05-24 Caritas St. Elizabeth's Medical Center of Boston, Inc., Boston VEGF ANGIOGENIC GROWTH FACTORS FOR THE TREATMENT OF PERIPHERAL NEUROPATHY
US7125856B1 (en) 1999-04-15 2006-10-24 St. Elizabeth's Medical Center Of Boston, Inc. Angiogenic growth factors for treatment of peripheral neuropathy
US8722862B2 (en) 2004-08-19 2014-05-13 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (en) 2006-02-27 2015-10-01 Biogen Idec Inc Treatments for neurological disorders
TWI445544B (en) 2007-05-01 2014-07-21 Biogen Idec Inc Compositions and methods for increasing vascularization
EP3538560A4 (en) 2016-11-10 2020-06-17 Keros Therapeutics, Inc. Gdnf fusion polypeptides and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135370T1 (en) * 1988-12-22 1996-03-15 Kirin Amgen Inc CHEMICALLY MODIFIED GRANULOCYTE COLONY EXCITING FACTOR
GEP20002243B (en) * 1991-09-20 2000-09-25 Amgen Inc Glial Derived Neurotrophic Factor
WO1993015722A1 (en) * 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
JPH07101990A (en) * 1993-10-01 1995-04-18 Sumitomo Metal Ind Ltd Neurotrophic factor
AU1443095A (en) * 1993-12-22 1995-07-10 University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
US5733875A (en) * 1994-11-15 1998-03-31 Amgen Inc. Methods of using GDNF as a neuroprotective agent

Also Published As

Publication number Publication date
WO1997019693A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
AU1534599A (en) Multiple range transition method and apparatus for process control sensors
AU6259096A (en) Spray drying method and apparatus
AU5332196A (en) Method for protein folding
AU7020396A (en) Multilayer dessert, and process and apparatus for its production
AU721035C (en) Modified aminoacids, pharmaceuticals containing these compounds and method for their production
AU5669896A (en) T1 channel bank control process and apparatus
AU1160195A (en) Leather coloring process, leather coloring apparatus, and colored leather produced by such process
AU5939496A (en) Method for spinal fusion without decortication
AU3243697A (en) System and method for materials process control
AU6990396A (en) Method and apparatus for making an extrusion product, and an extrusion product
AU5152996A (en) Method and apparatus for drying organic material
AU1121997A (en) Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product
AU7498596A (en) Sizing composition for glass strands, process using this composition and resulting products
AU2432495A (en) Structure forming method, apparatus and resulting product
AU7696896A (en) Dairy product and process for making same
EP0991986B8 (en) Method for process monitoring, control and adjustment
AU6445096A (en) Continuous process for producing high protein foodstuff and an apparatus useful therein
AU7658596A (en) Method and apparatus for temperature control
AU6704696A (en) Method for preparing inorganic pigments, resulting inorganic pigments, and apparatus therefor
AU2579395A (en) Color adjustment method and apparatus
AU7029796A (en) Method and apparatus for making glass
AU7277496A (en) Transport means control process
EP0929231B8 (en) Process for treating plant proteins and nutritional products made therefrom
EP0765608A3 (en) Method for manufacturing food products by using polyglycerol
AU5726999A (en) Method and apparatus for process control